Description

Glycimet-PG1 is commonly prescribed to manage type 2 diabetes mellitus. It contains two active ingredients: Metformin and Pioglitazone. Metformin helps lower blood sugar by improving insulin sensitivity and reducing glucose production in the liver. Pioglitazone also increases insulin sensitivity, helping the body use insulin more effectively to control blood sugar levels. Together, these help in maintaining better blood glucose control in diabetic patients.

Side Effects of Glycimet-PG1 Tablet:

• Common side effects:

  • Mild gastrointestinal issues such as nausea, vomiting, diarrhea, stomach upset, or loss of appetite

  • Headache or dizziness

• Less common but serious side effects:

  • Signs of lactic acidosis (rare but serious): muscle pain, weakness, difficulty breathing, unusual tiredness, or slow/irregular heartbeat

  • Swelling of ankles or feet

  • Weight gain or increased risk of heart failure (due to pioglitazone)

  • Allergic reactions such as rash, itching, or swelling

• Precautions:

  • Use with caution in patients with liver or kidney problems

  • Regular monitoring of blood sugar, liver function, and heart condition is advised